
Eli Lilly arthritis drug wins emergency approval for COVID-19 use
Arthritis drug baricitinib is authorised for emergency use in combination remdesivir to treat COVID-19 patients.
Arthritis drug baricitinib is authorised for emergency use in combination remdesivir to treat COVID-19 patients.